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Abstract
Background: Prevalence of infectious diseases in migrant populations has been addressed in
numerous studies. However, information is sparse on their mortality due to chronic diseases that
are aetiologically associated with an infectious agent. This study investigates mortality related to
infectious diseases with a specific focus on cancers of possibly infectious origin in voluntary migrants
from the Former Soviet Union residing in Israel and in Germany.
Methods: Both groups of migrants arrived from the Former Soviet Union in their destination
countries between 1990 and 2001. Population-based data on migrants in Israel were obtained from
the Israel Central Bureau of Statistics. Data for migrants in Germany were obtained from a
representative sample of all migrants from the Former Soviet Union in Germany. Cause of death
information was available until 2003 for the Israeli cohort and until 2005 for the German cohort.
Standardized mortality ratios were calculated relative to the destination country for selected
causes of death for which infectious agents may be causally involved. Multivariate Poisson
regression was applied to assess differences in mortality by length of residence in the host country.
Results: Both in Israel and in Germany these migrants have lower overall mortality than the
population in their destination countries. However, they have significantly elevated mortality from
viral hepatitis and from stomach and liver cancer when compared to the destination populations.
Regression analysis shows that in Israel stomach cancer mortality is significantly higher among
migrants at shorter durations of residence when compared to durations of more than nine years.
Conclusion: Higher mortality from cancers associated with infection and from viral hepatitis
among migrants from the Former Soviet Union might result from higher prevalence of infections
which were acquired in earlier years of life. The results highlight new challenges posed by diseases
of infectious origin in migrants and call attention to the link between communicable and non-
communicable diseases.
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Background
International migration is a growing phenomenon in our
globalized world. But although many studies on preva-
lence of infectious diseases in migrants and refugees are
available [1-4], mortality from these diseases is rarely con-
sidered. Even less attention is paid to mortality from
chronic diseases which may be caused by viral or bacterial
infectious agents [5].
A recently published study examined mortality from
avoidable causes by ethnic origin in the Netherlands. After
adjustment for age migrants experienced twice the risk
(RR) of death from diseases of infectious origin such as
pneumonia, HIV, liver cancer, viral hepatitis, tuberculosis,
and chronic rheumatic heart disease compared to native
Dutch. After adjustment for age, sex, marital status, urban-
ization level and area income the relative risk for migrants
remained high at 1.50 (1.32–1.72) [6].
Infectious agents involved in non-communicable diseases
considered in this paper are: Helicobacter pylori bacte-
rium (H. pylori), Hepatitis virus and human papilloma
viruses (HPV). H. pylori is classified by the International
Agency for Research on Cancer as a type I carcinogen [7]
and most stomach cancer and most peptic ulcers are
caused by H. pylori, which produces an active chronic gas-
tritis leading to chronic atropic gastritis [8,9]. H. pylori is
assumed as a cause of duodenal ulcers in about 70% of
cases and of gastric ulcer in about 60% of cases [9]. An
even stronger relationship is observed for gastric adeno-
carcinoma with H. pylori being present in more than 80%
of the cases [10].
An aetiological association with cervical cancer and its
precursors is known for HPV. High-risk HPV DNA is con-
sistently identified in cervical cancer patients [11]. Studies
suggest that prevalence of HPV might be higher in Russia
and other European parts of the Former Soviet Union
(FSU), although the distribution of types of human papil-
loma virus was found to be similar to other regions of the
world [12,13]. Infection in childhood and youth with
Hepatitis B virus is associated with the development of
liver cancer. High incidence of acute Hepatitis B and C is
paralleled by high incidence of chronic Hepatitis B and C
[14]. Initial hepatitis virus infection and H. pylori infec-
tion is likely to be acquired in earlier years of life [15,16]
and thus it can be assumed that chronic diseases caused by
infections in migrants reflect the country-specific risks
that migrants bring with them. The effect of immigration
from high and medium endemic areas on rising incidence
of Hepatitis B virus infections in the destination country
has been observed in Denmark [17], Sweden [18], and the
Netherlands [19].
Since 1990 the predominant region of origin of migrants
to Israel and Germany has been the FSU. Most migrants
from the FSU who came to Israel are of Jewish ethnicity,
particularly Ashkenazi Jews, whereas most of the migrants
from the FSU in Germany are descendants of ethnic Ger-
mans who settled in certain regions of Russia during the
18th Century. Both migrant groups were encouraged to
migrate on the basis of common ancestry and migrated
voluntarily. The study population in this investigation
consists of migrants from the European parts of the FSU
to Israel and of a representative sample of migrants from
these regions of the FSU in Germany who arrived between
1990 and 2001.
Recent studies conducted among these migrant popula-
tions have shown a lower overall mortality compared to
other Germans [20] and other Israelis [21]. However,
these studies concentrated on cancer mortality [22], exter-
nal causes of death [23,24], and on cardiovascular disease
mortality [20].
There is little information on which to base a comparison
of the prevalences of these infections in the FSU with that
in Germany or in Israel. Not enough is known about
infectious disease mortality in the FSU or about chronic
conditions caused by an infection in order to allow us to
determine the extent to which these migrants are affected
by their country of origin rates. Hepatitis viruses, particu-
larly Hepatitis B virus is more prevalent in many countries
in Eastern Europe and Russia than in Western Europe and
constitutes a major public health problem [25]. A study
among children in Moscow shows a high infection rate of
Hepatitis B and Hepatitis C viruses among patients with
liver diseases such as acute hepatitis, chronic hepatitis or
cirrhosis when compared to non-liver disease patients
[26]. The incidence of Hepatitis B and Hepatitis C has
grown since 1992 in Russia and was about 43.3 per
100,000 for Hepatitis B and 19.3 per 100,000 for Hepati-
tis C in 1999 with detection rates of HBsAg and anti-Hep-
atitis C virus being much higher among drug abusing
youth and among those who experienced sexual contacts
[14]. The burden of morbidity and premature mortality
from Hepatitis B virus infection varies across countries
within the FSU and is highest in the North West, Volga,
Ural, and East Siberian regions [14,27]. A high burden of
Hepatitis B is also found in St. Petersburg [28] and
Uzbekistan [29]. Germany is a country with low Hepatitis
B prevalence, and had a Hepatitis B incidence of 1.4 per
100,000 in 2006 [30]. A study estimated that about 84%
of foreign born people in Germany originated from coun-
tries with high or intermediate Hepatitis B endemicity,
among them migrants from the FSU [31]. Further esti-
mates show that of all HBsAg carriers in Germany, 42%
had a migration background, resulting in an increased riskBMC Public Health 2008, 8:110 http://www.biomedcentral.com/1471-2458/8/110
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for chronic infections among FSU-migrants and the for-
eign born in general [31].
Seroprevalence of H. pylori infection is also estimated to
be high in Russia, particularly among the Siberian Russian
population [16,32,33].
Migrants might be particularly vulnerable due to risk fac-
tor prevalence in their country of origin, as well as the
assimilation stress in the new country which could
increase risky health behaviour. This study assesses the
mortality from infectious diseases and diseases caused by
infectious agents among migrants from the FSU relative to
the mortality of their destination countries, Germany and
Israel. Given the size of the migrant populations relative
to their destination countries, the public health impact for
the receiving countries can be of considerable magnitude.
Methods
The population studied comprises regular migrants from
the FSU to Germany and to Israel who migrated voluntar-
ily and arrived between 1990 and 2001.
Selection procedures for the cohort of migrants to Ger-
many have been described elsewhere [20] and will be
reviewed briefly here. We used data from a cohort of
34,393 migrants who arrived from countries of the FSU,
mainly from the Russian Federation and Kazakhstan
between 1.1.1990 and 31.12.2001 and who were aged 15
years or older at arrival in Germany. FSU-migrants are ran-
domly distributed to federal states in Germany and the
study population was randomly selected from a dataset
which contains individual data of all 281,356 FSU-
migrants who arrived to North-Rhine-Westphalia, Ger-
many's most populous federal state. This random sample
was assumed to be representative for all FSU-migrants in
Germany [34]. The study is registry-based and utilization
of these data has been approved by the Federal Ministry of
the Interior of North-Rhine-Westphalia.
Data on migrants to Israel were obtained from the Israel
Central Bureau of Statistics (ICBS). Individual data were
assembled at the ICBS by matching electronic files of
administrative records of immigration and vital registra-
tion. Release of the data for analysis in an aggregate per-
son-years format was approved by the Data
Confidentiality Committee of the ICBS. The Israeli cohort
consists of all 589,388 migrants who arrived between
1.1.1990 and 31.12.2001 and were aged 15 years and
older at arrival in Israel and originated in the Russian Fed-
eration, Belarus, Ukraine, Moldova, the Baltic States
(Lithuania, Latvia, Estonia), and Kazakhstan. More than
three quarters of them were registered as Jews in Israel,
and the others were non-Jewish family members.
Persons were censored at their date of death or date of
moving out of the host country. For the cohort of migrants
to Germany, 31 December 2005 was the end of follow-up
whereas for the cohort of migrants to Israel it was 31
December 2003. Dates and causes of death for deceased
migrants in Israel were available from the ICBS for all
deaths which occurred between 1990 and 2001 and in
2003. For the year 2002 causes of death were not yet avail-
able.
Causes of death were coded professionally through the
official cause of death registration system at the Division
of Health Statistics of the ICBS and through the Federal
state office for data processing and statistics of North-
Rhine-Westphalia, Germany. Before 1998 causes were
coded according to the International Classification of Dis-
ease version 9, and thereafter according to version 10.
Person-years were calculated for each migrant cohort and
were broken down by sex, five-year age groups, calendar
year, length of stay, and immigration period. Sex-specific
standardized mortality ratios (SMRs) were calculated for
each migrant cohort separately using the country of desti-
nation as a reference. The SMR is defined as the ratio of
observed cases and the expected number of deaths. To
derive the expected number of deaths, age-, sex-, cause-,
and calendar year-specific mortality rates of the German
population were calculated based on mortality and popu-
lation data obtained from the World Health Organization
Mortality Database [35] and applied to the person-years
accumulated by the migrants in Germany. The reference
mortality rates for the Israeli cohort were obtained from a
file which contains age-, sex-, cause-, and calendar year-
specific mortality rates of all those Israelis who did not
arrive from the FSU between 1990 and 2004. Expected
numbers of death in the migrant cohort in Israel were cal-
culated applying their person-years to the specific rates of
the non-FSU migrant Israeli population.
SMRs were calculated for all causes of death, all infectious
diseases, and for the following causes: viral hepatitis
(ICD-9: 070/ICD-10: B15–B19), all malignant neoplasms
(ICD-9: 140–208/ICD-10: C00–C97), and for those
malignant neoplasms which are associated with infec-
tious agents: malignant neoplasm of stomach (ICD-9:
151/ICD-10: C16) and liver (ICD-9: 155/ICD-10: C22),
for males and females respectively, and malignant neo-
plasm of the cervix uteri (ICD-9: 180/ICD-10: C53) for
females. Additionally SMRs were calculated for rheumatic
fever and chronic rheumatic heart disease (ICD-9: 390–
398/ICD-10: I00–I09).
All 95% confidence intervals were calculated by the exact
method for number of death < 30 and by Wald-approxi-
mation for 30 or more observed deaths [36].BMC Public Health 2008, 8:110 http://www.biomedcentral.com/1471-2458/8/110
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To estimate the effect of lengths of residence on mortality
from viral hepatitis, stomach and liver cancer, regression
analyses was performed using Poisson regression models
for each migrant cohort and cause separately. Rate Ratios
(RR) were calculated using the logarithm of the person-
years as the offset term and were adjusted for sex, 5-year
age-group, and calendar year of death. The covariable
length of residence was categorized as less than 3 years, 3
to 5 years, 6 to 8 years, and 9 or more years of residence in
the destination country.
All calculations were performed using SAS Version 9.1
[37].
Results
Characteristics of both migrant cohorts from the FSU are
presented in Table 1. The cohorts differed greatly in size
with almost five million person-years accumulated by the
Israeli cohort and about 340,000 person-years accumu-
lated by the German cohort. Both cohorts were compara-
ble regarding their countries of origin and immigration
period.
Table 2 shows results of the mortality analysis. The overall
mortality of FSU-migrants in Germany and Israel for both
sexes combined was significantly lower than that of Ger-
mans and Israelis. In both cohorts, female migrants had a
greater advantage over the resident population than male
migrants.
While SMRs for all infectious and parasitic diseases were
not statistically significant, they were greater than one for
the migrants in Germany and less than one among
migrants in Israel. However, when compared to the host
populations, both sexes had an excess risk for viral hepa-
titis. Female and male migrants from the FSU in Germany
were almost four times more likely to die of viral hepatitis
than other Germans. Similarly, for FSU-migrants in Israel
there was a statistically significantly elevated risk of death
from viral hepatitis compared to other Israelis; however,
compared to the host population the difference was not as
great as in Germany with an SMR of 1.39 (95% confi-
dence interval: 1.25–1.53) for both sexes combined, see
Table 3
Discussion
We found in migrants from the FSU residing in Israel and
Germany a statistically significant elevated mortality risk
for viral hepatitis and for some cancers which are associ-
ated with infectious agents. This contrasts with the overall
mortality of these migrants, which was lower compared to
all Germans and other Israelis. Similarly, the SMRs for all
infectious and parasitic diseases (of which septicemia is
the largest subgroup) were not significantly elevated for
these migrants in Germany and even significantly lower
among these migrants in Israel when compared to the
host population.
After stratification by ethnicity of FSU-migrants in Israel
and other Israelis, female migrants of Jewish ethnicity had
a higher and statistically significant SMR for viral hepatitis
compared to other female Israelis of Jewish ethnicity
(result not shown). This might indicate that the non-Jew-
ish female population in Israel (mostly Arabs) has higher
viral hepatitis mortality, and including them in the refer-
ence population attenuates the SMR for female migrants
from the FSU. However, for all other examined causes of
death, the SMRs remain very similar when restricting the
analysis to persons of Jewish ethnicity.
The lower risk of mortality from acute rheumatic fever and
chronic rheumatic heart disease among FSU-migrants in
Israel may reflect differential certification of causes of
death in a population which has only recently arrived in
the medical system so that diagnosis may not have been
available. It is also possible that this is a selective effect
reflecting diminished survival from this chronic disease
before migration.
Table 1: Characteristics of migrants from the Former Soviet Union in Israel and Germany
Migrants to Israel Migrants to Germany
Country of origin Russian Federation, Russia, SU, Baltic States, Belarus, 
Ukraine, Moldova, Kazakhstan
Russian Federation, Russia, SU, Kazakhstan, Ukraine
Immigration Period 1990–2001 1990–2001
Immigration based on Law of Return of 1950 German Basic Constitutional Law, Art. 116
Age at arrival 15+ 15+
Number of cohort members 589388 34393
Person-years 4793089 344457
Deaths 48942 (1990–2001, 2003) 2580 (1990–2005)
Male deaths 22989 1334
Female deaths 25953 1246
Mortality follow-up 31.12.2003 31.12.2005BMC Public Health 2008, 8:110 http://www.biomedcentral.com/1471-2458/8/110
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Although overall cancer mortality of male FSU-migrants
in Germany was comparable to all Germans and lower in
female migrants, a higher risk was observed for stomach
cancer in both migrant populations when compared to
their destination countries. H.pylori is however only one
risk factor for gastric cancer and nutritional factors, such
as low fruit and vegetable consumption and high intake of
nitrite containing foods, also play an important role in the
pathogenesis of gastric cancer [38,39].
Alcohol consumption, in particular vodka consumption
which is very common in the FSU, was also found to
increase the risk of gastric cancer [40]. High alcohol con-
sumption, together with hepatitis virus infection, might
also provide an explanation for the significantly elevated
risk for liver cancer found in this study [41].
FSU-migrants in Germany and Israel at shorter durations
of stay show elevated mortality risks for stomach cancer.
An effect of length of stay was also observed in the Dutch
study by Stirbu et al [6] where the mortality risk difference
between recent and earlier migrants in the Netherlands
was particularly pronounced in the case of conditions of
infectious origin. Recent migrants of both sexes combined
showed a significantly higher risk of death from the exam-
ined diseases of infectious origin combined, compared to
those who resided in the Netherlands longer than 15
years.
Potential limitations of the study derive from the nature
of the data. Not all chronic conditions involving an infec-
tious agent are examined, e.g. due to the small number of
cases rheumatic heart disease was not examined for FSU-
migrants in Germany. The results presented here rely on
the quality of official death certificate data. FSU-migrants
and their reference populations were diagnosed and
coded in the same official system, so a bias is unlikely
here.
Since no information on prevalence and distribution of
risk factors such as infections, alcohol consumption and
poor diet are available, results are not adjusted for differ-
ences in these between host and migrant populations, and
we cannot conclude from our data that infection alone
explains the observed excess risks.
Differences might also be related to living conditions;
however, there is neither information available on cause-
specific mortality nor on infection rates of the Jewish or
ethnic German population of the FSU which would allow
specification of the mortality profile before migration and
thus allow identification of selection and possible assimi-
Table 2: Standardized Mortality Ratios (SMR) and 95% Confidence Intervals: Migrants aged 15+ from the Former Soviet Union relative 
to country of destination (Germany and Israel)
Germany* Israel**
Cases SMR (95% CI) Males Females Total Males Females Total
All Causes of Death 1334
0.93
(0.88–0.98)
1246
0.85
(0.80–0.90)
2580
0.89
(0.85–0.92)
22989
1.01
(1.00–1.03)
25953
0.91
(0.90–0.93)
48942
0.96
(0.95–0.97)
Infectious and parasitic dis. (ICD-9: 001–139 ICD-10: A00-B99) 20
1.19
(0.72–1.83)
23
1.40
(0.89–2.11)
43
1.29
(0.96–1.74)
475
0.96
(0.87–1.05)
524
0.75
(0.66–0.83)
999
0.84
(0.77–0.90)
Viral Hepatitis (ICD-9: 070 ICD-10: B15–B19) 9
4.51
(2.06–8.56)
6
3.33
(1.25–7.36)
15
3.98
(2.23–6.57)
109
1.63
(1.35–1.96)
89
1.18
(0.97–1.38)
198
1.39
(1.25–1.53)
All Malignant Neoplasms (ICD-9: 140–208 ICD-10: C00–C97) 409
1.01
(0.92–1.11)
299
0.79
(0.71–0.89)
708
0.91
(0.84–0.98)
6498
1.21
(1.19–1.24)
7567
1.15
(1.13–1.17)
14065
1.18
(1.16–1.20)
Stomach (ICD-9: 151 ICD-10:C16) 37
1.44
(1.04–1.99)
31
1.40
(0.98–1.99)
68
1.42
(1.12–1.80)
585
1.80
(1.71–1.88)
491
1.83
(1.74–1.91)
1067
1.81
(1.75–1.87)
Liver (ICD-9: 155 ICD-10:C22) 18
1.55
(0.99–2.45)
12
1.80
(0.93–3.15)
30
1.64
(1.15–2.35)
188
1.35
(1.21–1.50)
181
1.29
(1.14–1.43)
369
1.32
(1.22–1.42)
Cervix uteri (ICD- 9: 180 ICD-10: C53) - 7
0.82
(0.33–1.68)
-- 8 3
1.09
(0.88–1.31)
-
Rheum. fever and chronic rheumatic heart disease (ICD-9: 390–
398 ICD-10: I00–I09)
-3
0.52
(0.17–1.62)
-3 3
0.76
(0.41–1.10)
112
0.86
(0.68–1.05)
145
0.84
(0.67–1.00)
* Migrants in Germany, 1990–2005, relative to all Germans.
** Migrants in Israel, 1990–2001, 2003, relative to other Israelis.BMC Public Health 2008, 8:110 http://www.biomedcentral.com/1471-2458/8/110
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lation effects. In this regard, the general problem of the
absence of ethnic-specific mortality data in studies using
administrative data limits the potential for interpretation
of the results presented here. However, further studies
base on these data will aim at a comparison of mortality
of these migrants with the country of origin using the Rus-
sian Federation mortality rates as a general reference.
It is unlikely that the mortality differences reflect differen-
tial treatment by the health care system. In Israel as well as
in Germany, FSU-migrants are covered by universal health
insurance and have access to diagnostic and medical serv-
ices. Nevertheless, their health seeking behavior might be
different than that of the host population, and some fea-
tures of the health systems may function less adequately
for migrants.
Conclusion
This study suggests and highlights new challenges posed
by diseases of infectious origin in migrants and calls atten-
tion to the link between communicable and non-commu-
nicable diseases. Infectious agents show association with
a broad range of otherwise non-communicable diseases as
in the case of H. pylori which can also affect organ systems
outside the gastrointestinal tract such as skin, liver and
heart [9].
To combat the burden of disease and mortality from these
avoidable diseases, particularly elevated in minority
groups, greater attention has to be paid to reduce infec-
tions, by treatment or by vaccination. Universal immuni-
zation intervention against Hepatitis B virus, particularly
targeted towards children and adolescents, can limit the
rapid spread of Hepatitis B in the countries of the FSU
[14,28,29,42].
Public health initiatives are important to follow other risk
factors most prevalent in the FSU such as alcohol and
tobacco consumption. Since Hepatitis B virus is often
transmitted intravenously and Hepatitis B incidence
increased significantly among young adults in the Russian
Federation between 1997 and 2002 [42] preventive action
Table 3: Rate Ratios (RR) and 95% Confidence Intervals: Internal comparison among FSU-migrants in Israel and Germany aged 15+ by 
length of residence
Person-Years Rate Ratios* (95% Confidence Intervals)
Viral Hepatitis Stomach Cancer Liver Cancer Rheum. fever/
rheum. heart 
disease
Years of 
residence
Germany Israel Germany Israel Germany Israel Germany Israel Israel
0–2 123046 1657868 0.75
(0.14 – 3.88)
0.67
(0.41 – 1.10)
1.25
(0.63 – 2.48)
1.88
(1.53 – 2.33)
0.79
(0.29 – 2.17)
0.86
(0.63 – 1.19)
1.74
(0.97 – 3.11)
3–5 99301 1375751 1.06
(0.23 – 4.93)
1.29
(0.83 – 2.02)
0.92
(0.44 – 1.92)
1.58
(1.28 – 1.96)
0.73
(0.26 – 2.07)
0.74
(0.54 – 1.03)
1.47
(0.81 – 2.64)
6–8 64964 1024203 1.77
(0.41 – 7.53)
1.28
(0.81 – 2.01)
1.15
(0.55 – 2.39)
1.40
(1.12 – 1.75)
0.96
(0.34 – 2.67)
0.93
(0.68 – 1.28)
2.09
(1.19 – 3.67)
9+ 57145 735267 1.00 1.00 1.00 1.00 1.00 1.00 1.00
For all malignant neoplasms, both sexes of migrants to Germany combined and female migrants specifically, had statistically significantly lower 
mortality than Germans. Both sexes of FSU-migrants in Israel show a statistically significant excess mortality risk for all malignant neoplasms 
compared to the population in their destination country.
Although a difference in all cancer mortality was observed between the migrant cohorts, both had statistically significant increased risks for two of 
the cancer sites examined which are associated with infectious agents. Among the migrants in Germany the risk of dying of stomach cancer was 
almost one and a half times that of male and female Germans, respectively. And among migrants in Israel the risk of dying of this cause was almost 
double that of other Israelis, for each sex. In both countries these differences were statistically significant. Similarly, the mortality risk of liver cancer 
relative to Germans was higher for both sexes with a joint SMR of 1.64 (95% CI: 1.15–2.35) relative to German rates. For the migrants in Israel the 
SMR was 1.32 (95% CI: 1.22–1.42) compared to other Israelis. No significant differences in cervical cancer mortality were found between migrants 
and the host population in Israel and Germany, respectively. For both sexes combined the mortality risk for acute rheumatic fever and chronic 
rheumatic heart disease for migrants in Israel was lower than for other Israelis and statistically significant. For German migrants no meaningful 
statement can be made due to the small number of deaths from this cause.
Table 3 shows results from the multivariate analysis which was carried out to assess mortality differences by length of residence in the host 
country. No clear pattern was observed for viral hepatitis and liver cancer. For cervical cancer, numbers were too small for this analysis. However, 
stomach cancer mortality in FSU-migrants was affected by length of residence, indicating mortality risks were reduced after lengths of residence of 
nine years in Israel. Migrants in their first two years of residence had almost twice the risk of dying from stomach cancer as those who lived in Israel 
for more than nine years. This result was not influenced by arrival cohort as no differences were found between migrants who arrived in the early 
or the late 1990s (result not shown). For rheumatic fever it also appears that the risk was reduced after 9 years in Israel, but here the pattern is 
weaker and only the category of 6–8 years in Israel was statistically significant.
* Adjusted for sex, age, immigration periodBMC Public Health 2008, 8:110 http://www.biomedcentral.com/1471-2458/8/110
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is also necessary regarding drug abuse and sexual behav-
iour.
The scale of migration has undergone major shifts in the
era of globalization and likewise migration-associated
classical infectious diseases have changed with changing
source populations [15,43]. Liberalization of immigra-
tion policies in Western Europe may further affect interna-
tional population movements with more people
migrating from the FSU and other Eastern European coun-
tries. Given the intermediate to high endemicity of Hepa-
titis B virus in the FSU, chronic diseases driven by these
agents might become of increasing public health rele-
vance for both the receiving and sending countries.
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